Oncological long-term outcomes of laparoscopic versus open gastrectomy for cT3-4 gastric cancer at surgical staging: a propensity-score matched cohort study
Surgical Endoscopy · 2024
DOI: 10.1007/s00464-024-11287-8 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Arrieta G Manuel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Propensity Score, Laparoscopy. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The oncological efficacy of laparoscopic surgery for advanced gastric cancer (AGC) has been evaluated by several randomized trials. However, the inclusion of earlier-stage disease was a limitation in previous studies. METHODS: Patients with cT3-4 gastric cancer, determined by surgical staging to minimize migration of earlier stages, treated at a tertiary cancer center from 2009 to 2018 were included. Based on the surgical approach, the patients were divided into two groups: the laparoscopic gastrectomy (LG) and the open gastrectomy (OG) and matched for age, sex, macroscopic appearance (type 4 or non-type 4), body mass index, estimated tumor size, clinical stage T3'T4, clinical N stage, pathologic T stage (T3 or T4), and type of surgery (total or distal gastrectomy). RESULTS: 588 patients (221 LG, 367 OG) were included in the analysis. After 1:1 propensity-score matching, 386 patients (193 LG, 193 OG) were assigned for analysis. In the LG group, operation time was longer with lower blood loss. The incidence of postoperative complications (≥ grade III) did not differ significantly between the groups (OG: 8.3%, vs. LG: 9.3%). Overall survival (OS) was longer in the LG group (5-year OS: 79.3 vs. 73% HR 0.66, 95% CI 0.44-0.99, P = 0.0497). Relapse-free survival (RFS) did not show a statistical difference (5-year RFS: 69.5 vs. 68.7 HR 0.88, 95% CI 0.62-1.26, P = 0.487). Subgroup analysis for OS also demonstrated equivalent outcomes. CONCLUSION: LG demonstrates comparable safety and efficacy to OG for advanced gastric cancer at surgical staging, with similar rates of severe complications and long-term oncological outcomes. Further research is needed to validate these findings, particularly for total gastrectomy and for patients from Western populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan. takkinos@east.ncc.go.jp.
- Gastric Surgery Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. takkinos@east.ncc.go.jp.
- Department of Surgical Oncology, Northwell Health, North Shore/Long Island Jewish, New Hyde Park, NY, USA.
ORCID-Profile: Takahiro Kinoshita
Zitieren
APA
Manuel, A. G., Kinoshita, T., Amini, N., Akimoto, E., Yura, M., Yoshida, M., Habu, T., Nagata, H., Komatsu, M., Sano, J., & Terajima, D. (2024). Oncological long-term outcomes of laparoscopic versus open gastrectomy for cT3-4 gastric cancer at surgical staging: a propensity-score matched cohort study. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-11287-8
Vancouver
Manuel AG, Kinoshita T, Amini N, Akimoto E, Yura M, Yoshida M, et al. Oncological long-term outcomes of laparoscopic versus open gastrectomy for cT3-4 gastric cancer at surgical staging: a propensity-score matched cohort study. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-11287-8
BibTeX
@article{Manuel2024,
author = {Manuel, Arrieta G and Kinoshita, Takahiro and Amini, Neda and Akimoto, Eigo and Yura, Masahiro and Yoshida, Mitsumasa and Habu, Takumi and Nagata, Hiromi and Komatsu, Masaru and Sano, Junichi and Terajima, Daiki},
title = {Oncological long-term outcomes of laparoscopic versus open gastrectomy for cT3-4 gastric cancer at surgical staging: a propensity-score matched cohort study},
journal = {Surgical Endoscopy},
year = {2024},
doi = {10.1007/s00464-024-11287-8}
}
EUVIMED